Methoxamine
| Clinical data | |
|---|---|
| Trade names | Vasoxine, Vasoxyl, Vasylox, others |
| Other names | Methoxamedrine; 2,6-Dimethoxy-β-hydroxy-α-methylphenethylamine; 2,6-Dimethoxy-β-hydroxyamphetamine |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral, injection[1] |
| ATC code | |
| Pharmacokinetic data | |
| Elimination half-life | 3 hours |
| Excretion | Urine |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.244 |
| Chemical and physical data | |
| Formula | C11H17NO3 |
| Molar mass | 211.261 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Methoxamine, sold under the brand names Vasoxine, Vasoxyl, and Vasylox among others, is a sympathomimetic medication used as an antihypotensive agent.[2][3][4][5] It has mostly or entirely been discontinued.[6]
The drug is an α1-adrenergic receptor agonist.[4]
- ^ Cite error: The named reference
Drugs@FDAwas invoked but never defined (see the help page). - ^ Thiele RH, Nemergut EC, Lynch C (August 2011). "The physiologic implications of isolated alpha(1) adrenergic stimulation". Anesth Analg. 113 (2): 284–296. doi:10.1213/ANE.0b013e3182124c0e. PMID 21519050.
- ^ Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 788. ISBN 978-1-4757-2085-3. Retrieved 2024-09-01.
- ^ a b Cite error: The named reference
IndexNominum2000was invoked but never defined (see the help page). - ^ Pazdernik TL, Kerecsen L (2007) [2003]. "5". In Goljan EF (ed.). Pharmacology. Rapid Review (Second ed.). Philadelphia, PA: Mosby-Elsevier. p. 39. ISBN 978-0-323-04550-6.
- ^ Cite error: The named reference
Drugs.com-Internationalwas invoked but never defined (see the help page).